John Ford is the founder of Enterprise Therapeutics. Enterprise Therapeutics has raised $41M in total funding. Latest round: Series B.
John Ford is the CEO of Enterprise Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for respiratory diseases. He led the company through its Series B funding round of £29 million ($41 million) in 2018. Ford also previously founded Dezima.
Full founder directory · Investor directory · Company funding database · Fundraising library